Assessment of Pharmacovigilance Across University Hospitals in Morocco
Drug Safety · 2025
DOI: 10.1007/s40264-025-01517-w ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Safety, 2025. Verfasst von Hind Hamzaoui und 9 weiteren Autor:innen. Beteiligte Einrichtung: Centre Anti Poison et Pharmacovigilance du Maroc, Ministry of Health, Rabat, Morocco. Hauptthemen laut MEDLINE: Pharmacovigilance, Hospitals, University, Adverse Drug Reaction Reporting Systems, COVID-19. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Intramural CDC HHS, CDC HHS, Centers for Disease Control and Prevention.
Abstract (Originalsprache)
Introduction
Despite the increased scrutiny on vaccine safety following the coronavirus disease 2019 (COVID-19) pandemic, Morocco’s Centre of Antipoison and Pharmacovigilance (CAPM) remained concerned that the pharmacovigilance system in Morocco was insufficiently implemented, including limited adverse event (AE) reporting, poor data use, and inconsistent training nationwide.
Objectives
We sought to assess the status of pharmacovigilance activities (PAs) prior to formally institutionalizing them across university hospital centers (UHCs), given their position as the main providers of healthcare in Morocco and key sources for reporting serious AEs.
Methods
We assessed seven UHCs (housing 30 hospitals) in 2023 using a structured questionnaire with pharmacovigilance focal points developed from the World Health Organization’s indicators of pharmacovigilance and the Global Benchmarking Tool. Data were grouped into 28 PAs and scored from 0 (not implemented) to 3 (fully implemented). We then calculated an implementation rate for each site on the basis of percent of PAs fully implemented (≥ 70%, well established; > 40% to < 70%, partially implemented; and ≤ 40%, not implemented). A desk review was also performed at the sites. Using the results of the assessment, three working groups of pharmacovigilance stakeholders developed recommendations to be formally adopted by UHCs.
Results
Basic elements of pharmacovigilance (notification forms and VigiFlow ® or Excel databases) were present at all the UHCs assessed. In total, 14 hospitals (47%) had well-established PAs, including advanced activities such as signal detection of adverse events following the use of medicines and vaccines, as well as causality assessment; 9 hospitals (30%) were partially implementing pharmacovigilance, and 7 hospitals (23%) had no established activities or very basic activities. Within four UHCs, activities had not been implemented at the same level from one hospital to another and vaccine vigilance was largely deprioritized. The working groups made recommendations for improving collaboration, standardizing procedures, and outlining a new organizational structure for pharmacovigilance, which was institutionalized by a formal agreement among UHCs in July 2023.
Conclusions
The assessment revealed a subgroup of centers with well-established AE signal detection and causality assessment abilities, which could play a leading role in the country. After the site assessment, our collaborative approach of bringing together focal points to identify next steps and generate buy-in helped to formalize pharmacovigilance across centers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Centre Anti Poison et Pharmacovigilance du Maroc, Ministry of Health, Rabat, Morocco.
- US Centers for Disease Control and Prevention, Atlanta, USA.
- Private Consultant, Rabat, Morocco.
- Centre Anti Poison et Pharmacovigilance du Maroc, Ministry of Health, Rabat, Morocco. r.soulaymani@pharmacovigilance.ma.
Förderung
- Intramural CDC HHS
- CDC HHS
- Centers for Disease Control and Prevention
Zitieren
APA
Hamzaoui, H., Shaum, A., Cherkaoui, I., Moussa, L. A., Sefiani, H., Talibi, I., Benabdallah, G., Salman, O., Ferrey, S., & Soulaymani Bencheikh, R. (2025). Assessment of Pharmacovigilance Across University Hospitals in Morocco. Drug Safety. https://doi.org/10.1007/s40264-025-01517-w
Vancouver
Hamzaoui H, Shaum A, Cherkaoui I, Moussa LA, Sefiani H, Talibi I, et al. Assessment of Pharmacovigilance Across University Hospitals in Morocco. Drug Safety. 2025. doi:10.1007/s40264-025-01517-w
BibTeX
@article{Hamzaoui2025,
author = {Hamzaoui, Hind and Shaum, Anna and Cherkaoui, Imad and Moussa, Latifa Ait and Sefiani, Houda and Talibi, Ismail and Benabdallah, Ghita and Salman, Omar and Ferrey, Seth and Soulaymani Bencheikh, Rachida},
title = {Assessment of Pharmacovigilance Across University Hospitals in Morocco},
journal = {Drug Safety},
year = {2025},
doi = {10.1007/s40264-025-01517-w}
}
EUVIMED